On March 13, the U.S. Food and Drug Administration was alerted to five cases of acute non-viral hepatitis (resulting in acute liver failure) in infants and young children that occurred in November 2020 with an unknown cause reported to the Southern Nevada Health District.
All five patients had been hospitalized but have since recovered. All patients were reported to have consumed “Real Water” brand alkaline water. These patients came from four different households. Additional people in the households were reported to have experienced less severe symptoms. Less severe symptoms included fever, vomiting, nausea, loss of appetite and fatigue.
The consumption of “Real Water” brand alkaline water is the only common link identified between all of these cases to date. This brand of alkaline water is owned by Real Water Inc., headquartered in Mesa, Arizona.
Frank Yiannas, Deputy Commissioner for Food Policy and Response said, “The FDA is committed to protecting the health of Americans and is especially concerned when there is a food safety issue impacting our youngest, and some of the most vulnerable in the population – infants and young children. Upon learning about reports of acute non-viral hepatitis in Nevada, impacting five young children, the FDA quickly activated a team to further investigate. We are working closely with the CDC, state and local partners to complete our investigation and monitor for any additional illnesses.
“We are advising consumers, restaurants and retailers to not consume, cook with, sell or serve “Real Water” alkaline water until more information is known about the cause of the illnesses. We are working to determine how the alkaline water may be related to the illnesses. Although the investigation is ongoing, CDC’s analysis of epidemiologic information indicates that this alkaline water product may be the cause of the illnesses. We will provide additional updates as more information becomes available.”
- UK variant of SARS-CoV-2 spread rapidly in care homes in England in November and December last year
- Colorado: Suspected norovirus increases reported in Mesa County child care centers
- Sweden pauses use of AstraZeneca’s COVID-19 vaccine pending investigation
- Ebola in DRC: 1500 vaccinated, Healthcare providers threaten strike
- MRSA: KIMYRSA (oritavancin) receives FDA approval for treatment of ABSSSI
- Spain suspends AstraZeneca COVID-19 vaccine for the next two weeks
- Legionnaires’ Disease cluster reported in north New Jersey